A quantitative systems pharmacology framework of immunogenicity to propose mitigation strategies after subcutaneous administration Oral presentation, GMP Symposium 2024 Selvaggio G, Pellowe M, Chenel M, Sjögren E. ConferenceMethodologySpecial considerations Pharmetheus Affiliates Director, MIDD Consultant Gianluca Selvaggio See bio Director, MIDD Consultant Moriah Pellowe See bio Chief Research Officer Marylore Chenel See bio Principal Director, PBPK & PBBM Scientific Lead Erik Sjögren See bio
